1-17 of 17
Jerold E. Rehg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1667: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity

Casey G. Langdon, Katherine E. Gadek, Matthew R. Garcia, Myron K. Evans, Kristin B. Reed, Madeline Bush, Jason A. Hanna, Catherine J. Drummond, Matthew C. Maguire, Patrick J. Leavey, David Finkelstein, Hongjian Jin, Patrick A. Schreiner, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1667.
https://doi.org/10.1158/1538-7445.AM2022-1667
Published: 15 June 2022
View article titled, Abstract 1667: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
Journal Articles

Abstract 3022: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma indentity

Casey G. Langdon, Katherine E. Gadek, Matthew R. Garcia, Kristin B. Reed, Madeline Bush, Jason A. Hanna, Catherine J. Drummond, Matthew C. Maguire, Patrick J. Leavey, David Finkelstein, Hongjian Jin, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 3022.
https://doi.org/10.1158/1538-7445.AM2021-3022
Published: 01 July 2021
View article titled, Abstract 3022: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma indentity
Journal Articles

The Common Germline TP53-R337H Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model

John R. Jeffers, Emilia M. Pinto, Jerold E. Rehg, Michael R. Clay, Jinling Wang, Geoffrey Neale, Richard J. Heath, Guillermina Lozano, Enzo Lalli, Bonald C. Figueiredo, Alberto S. Pappo, Carlos Rodriguez-Galindo, Wenan Chen, Stanley Pounds, Raul C. Ribeiro, Gerard P. Zambetti
Journal: Cancer Research
Series: Author Choice
Cancer Res (2021) 81 (9): 2442–2456.
https://doi.org/10.1158/0008-5472.CAN-20-1750
Published: 01 May 2021
View article titled, The Common Germline <em>TP53-R337H</em> Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model
Open the PDF for The Common Germline <em>TP53-R337H</em> Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model in another window
Includes: Supplementary data
Journal Articles

Abstract 4631: Modeling the vascular sarcoma spectrum with genetically engineered mice

Jason A. Hanna, Casey G. Langdon, Matthew R. Garcia, David Finkelstein, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4631.
https://doi.org/10.1158/1538-7445.AM2019-4631
Published: 01 July 2019
View article titled, Abstract 4631: Modeling the vascular sarcoma spectrum with genetically engineered mice
Journal Articles

Abstract PR12: Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from nonmyogenic endothelial progenitors

Catherine J. Drummond, Jason A. Hanna, Matthew R. Garcia, Daniel J. Devine, Alana J. Heyrana, David Finkelstein, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2018) 78 (19_Supplement): PR12.
https://doi.org/10.1158/1538-7445.PEDCA17-PR12
Published: 01 October 2018
View article titled, Abstract PR12: Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from nonmyogenic endothelial progenitors
Journal Articles

Abstract A31: Biallelic Dicer1 loss in endothelial cells drives angiosarcoma development

Jason A. Hanna, Catherine J. Drummond, Matthew R. Garcia, Jonathan C. Go, David Finkelstein, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2018) 78 (10_Supplement): A31.
https://doi.org/10.1158/1538-7445.MOUSEMODELS17-A31
Published: 14 May 2018
View article titled, Abstract A31: Biallelic Dicer1 loss in endothelial cells drives angiosarcoma development
Journal Articles

Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma

Jason A. Hanna, Catherine J. Drummond, Matthew R. Garcia, Jonathan C. Go, David Finkelstein, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2017) 77 (22): 6109–6118.
https://doi.org/10.1158/0008-5472.CAN-17-1262
Published: 14 November 2017
View article titled, Biallelic <em>Dicer1</em> Loss Mediated by <em>aP2-Cre</em> Drives Angiosarcoma
Open the PDF for Biallelic <em>Dicer1</em> Loss Mediated by <em>aP2-Cre</em> Drives Angiosarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract 461: Dichotomous roles of Dicer1 in rhabdomyosarcoma and angiosarcoma

Jason A. Hanna, Matthew R. Garcia, Catherine J. Drummond, Jonathon C. Go, David Finkelstein, Jerold E. Rehg, Mark E. Hatley
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 461.
https://doi.org/10.1158/1538-7445.AM2017-461
Published: 01 July 2017
View article titled, Abstract 461: Dichotomous roles of Dicer1 in rhabdomyosarcoma and angiosarcoma
Journal Articles

Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis

Tal Teitz, Madoka Inoue, Marcus B. Valentine, Kejin Zhu, Jerold E. Rehg, Wei Zhao, David Finkelstein, Yong-Dong Wang, Melissa D. Johnson, Christopher Calabrese, Marcelo Rubinstein, Razqallah Hakem, William A. Weiss, Jill M. Lahti
Journal: Cancer Research
Series: Author Choice
Cancer Res (2013) 73 (13): 4086–4097.
https://doi.org/10.1158/0008-5472.CAN-12-2681
Published: 30 June 2013
View article titled, Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
Open the PDF for Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis in another window
Includes: Supplementary data
Journal Articles

Abstract 3617: The multikinase inhibitor sorafenib enhances the activity of cytarabine in a mouse xenograft model of acute myeloid leukemia (AML)

Shuiying Hu, Hongmei Niu, Hiroto Inaba, Stanley Pounds, Jerold E. Rehg, Sharyn D. Baker
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3617.
https://doi.org/10.1158/1538-7445.AM10-3617
Published: 15 April 2010
View article titled, Abstract 3617: The multikinase inhibitor sorafenib enhances the activity of cytarabine in a mouse xenograft model of acute myeloid leukemia (AML)
Journal Articles

p18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1–Driven Primitive Neuroectodermal Tumor

Raya Saab, Carlos Rodriguez-Galindo, Kelly Matmati, Jerold E. Rehg, Shannon H. Baumer, Joseph D. Khoury, Catherine Billups, Geoffrey Neale, Kathleen J. Helton, Stephen X. Skapek
Journal: Cancer Research
Cancer Res (2009) 69 (2): 440–448.
https://doi.org/10.1158/0008-5472.CAN-08-1892
Published: 15 January 2009
View article titled, <em>p18<sup>Ink4c</sup></em> and <em>p53</em> Act as Tumor Suppressors in <em>Cyclin D1</em>–Driven Primitive Neuroectodermal Tumor
Open the PDF for <em>p18<sup>Ink4c</sup></em> and <em>p53</em> Act as Tumor Suppressors in <em>Cyclin D1</em>–Driven Primitive Neuroectodermal Tumor in another window
Includes: Supplementary data
Journal Articles

The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib

Jennifer S. Carew, Steffan T. Nawrocki, Venudhar K. Reddy, Dorothy Bush, Jerold E. Rehg, Andrew Goodwin, Janet A. Houghton, Robert A. Casero, Jr, Laurence J. Marton, John L. Cleveland
Journal: Cancer Research
Cancer Res (2008) 68 (12): 4783–4790.
https://doi.org/10.1158/0008-5472.CAN-07-6483
Published: 16 June 2008
View article titled, The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib
Open the PDF for The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib in another window
Includes: Supplementary data
Journal Articles

Differential Effects of Targeted Disruption of Thiopurine Methyltransferase on Mercaptopurine and Thioguanine Pharmacodynamics

Christine Hartford, Erick Vasquez, Matthias Schwab, Mathew J. Edick, Jerold E. Rehg, Gerard Grosveld, Ching-Hon Pui, William E. Evans, Mary V. Relling
Journal: Cancer Research
Cancer Res (2007) 67 (10): 4965–4972.
https://doi.org/10.1158/0008-5472.CAN-06-3508
Published: 17 May 2007
View article titled, Differential Effects of Targeted Disruption of Thiopurine Methyltransferase on Mercaptopurine and Thioguanine Pharmacodynamics
Open the PDF for Differential Effects of Targeted Disruption of Thiopurine Methyltransferase on Mercaptopurine and Thioguanine Pharmacodynamics in another window
Journal Articles

Genetic Alterations in Mouse Medulloblastomas and Generation of Tumors De novo from Primary Cerebellar Granule Neuron Precursors

Frederique Zindy, Tamar Uziel, Olivier Ayrault, Christopher Calabrese, Marc Valentine, Jerold E. Rehg, Richard J. Gilbertson, Charles J. Sherr, Martine F. Roussel
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2676–2684.
https://doi.org/10.1158/0008-5472.CAN-06-3418
Published: 15 March 2007
View article titled, Genetic Alterations in Mouse Medulloblastomas and Generation of Tumors <em>De novo</em> from Primary Cerebellar Granule Neuron Precursors
Open the PDF for Genetic Alterations in Mouse Medulloblastomas and Generation of Tumors <em>De novo</em> from Primary Cerebellar Granule Neuron Precursors in another window
Includes: Supplementary data
Journal Articles

Hemangiosarcomas, Medulloblastomas, and Other Tumors in Ink4c/p53 -null Mice

Frederique Zindy, Lisa M. Nilsson, Luc Nguyen, Cecile Meunier, Richard J. Smeyne, Jerold E. Rehg, Charles Eberhart, Charles J. Sherr, Martine F. Roussel
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5420–5427.
Published: 18 September 2003
View article titled, Hemangiosarcomas, Medulloblastomas, and Other Tumors in <em>Ink4c/p53</em> -null Mice
Open the PDF for Hemangiosarcomas, Medulloblastomas, and Other Tumors in <em>Ink4c/p53</em> -null Mice in another window
Journal Articles

Loss of Bax Alters Tumor Spectrum and Tumor Numbers in ARF-deficient Mice

Christine M. Eischen, Jerold E. Rehg, Stanley J. Korsmeyer, John L. Cleveland
Journal: Cancer Research
Cancer Res (2002) 62 (7): 2184–2191.
Published: 01 April 2002
View article titled, Loss of Bax Alters Tumor Spectrum and Tumor Numbers in ARF-deficient Mice
Open the PDF for Loss of Bax Alters Tumor Spectrum and Tumor Numbers in ARF-deficient Mice in another window
Journal Articles

Biochemical Pharmacology of 2-Chlorodeoxyadenosine in Malignant Human Hematopoietic Cell Lines and Therapeutic Effects of 2-Bromodeoxyadenosine in Drug Combinations in Mice

Thomas L. Avery, Jerold E. Rehg, Wendy C. Lumm, Franklin C. Harwood, Victor M. Santana, Raymond L. Blakley
Journal: Cancer Research
Cancer Res (1989) 49 (18): 4972–4978.
Published: 01 September 1989
View article titled, Biochemical Pharmacology of 2-Chlorodeoxyadenosine in Malignant Human Hematopoietic Cell Lines and Therapeutic Effects of 2-Bromodeoxyadenosine in Drug Combinations in Mice
Open the PDF for Biochemical Pharmacology of 2-Chlorodeoxyadenosine in Malignant Human Hematopoietic Cell Lines and Therapeutic Effects of 2-Bromodeoxyadenosine in Drug Combinations in Mice in another window